| back 5 - the general term for a substance that prevents or delays
coagulation of the blood
|
front 6 Activated partial thromboplastin time (aPTT) | back 6 - a laboratory test used to measure the effectiveness of heparin
therapy
|
front 7 Prothrombin time (PT) & International Normalized Ratio (INR) | back 7 - two tests used to monitor the effects of drug therapy with
warfarin sodium
|
front 8 International Normalized Ratio (INR) | back 8 - a standardized measure of the degree of coagulation achieved by
drug therapy with warfarin sodium
|
| back 9 - a substance that reverses the effect of heparin
|
| back 10 - a substance that reverses the effect of warfarin sodium
|
| back 11 - a pharmaceutically available tissue plasminogen activator (tPA)
that is created through recombinant DNA techniques
|
| back 12 - a blood clot that dislodges and travels through the
bloodstream
|
front 13 The nurse is reviewing the use of anticoagulants. Anticoagulant
therapy is appropriate for which conditions. (Select all that apply) | |
front 14 During teaching of a patient who will be taking warfarin sodium
(Coumadin) at home, which statement by the nurse is correct regarding
over-the-counter drug use? | |
front 15 A patient is at risk for a stroke. Which drug is recommended to
prevent platelet aggregation for stroke prevention by the American
Stroke Society? | |
front 16 When administering subcutaneous heparin, the nurse will remember to
perform which action? | |
front 17 During thrombolytic therapy, the nurse monitors for bleeding. Which
symptoms may indicate a serious bleeding problem? (select all that apply) | |
front 18 Which drug is most often used for deep vein thrombosis (DVT)
prevention after major orthopedic surgery, even after the patient has
gone home? | |
front 19 The nurse is preparing a patient's morning medications and, upon
reviewing the list of drugs, notes that the patient is to receive
heparin 5,000 units and enoxaparin (Lovenox), both subcutaneously.
What is the nurse's priority action at this time? | |
front 20 The nurse is monitoring a patient who is receiving antithrombolytic
therapy in the emergency department because of a possible MI. Which
adverse effect would be of the greatest concern at this time? | |
front 21 A patient is receiving instructions regarding warfarin therapy and
asks the nurse about what medications she can take for headaches. The
nurse will tell her to avoid which type of medication? | |
front 22 The nurse is teaching a patient about self-administration of
enoxaparin (Lovenox). Which statement should be included in this
teaching session? | |
front 23 A patient is receiving dabigatran (Pradaxa), 150 mg twice daily, as
part of treatment for atrial fibrillation. Which condition, if
present, would be a concern if the patient were to receive this dose? | |
front 24 A patient has received a double dose of heparin during surgery and is
bleeding through the incision site. While the surgeons are working to
stop the bleeding at the incision site, the nurse will prepare to take
what action at this time? | |
front 25 A patient is starting warfarin (Coumadin) therapy as part of
treatment for atrial fibrillation. The nurse will follow which
principles of warfarin therapy? (select all that apply) | |
front 26 Before deciding whether the patient receives Heparin or a low
molecular-weight heparin (Enoxaparin), what are you looking for in
your assessment of the patient? | back 26 - Assess past medical history for contraindications (chronic
bleeding disorders such as hemophilia, renal disease (enoxaparin)
peptic ulcers (can increase the chance of GI bleeding)
- Assess current medical issues (acute bleeding processes,
hemorrhagic stroke, epidural catheter (enoxaparin)
- Assess
current medications (look for drug interactions, aspirin, NSAIDS,
garlic, other anticoagulants, antiplatelets, thrombolytics)
- Assess baseline labs (heparin- aPTT, platelets; enoxaparin-
platelets, creatinine clearance
|
front 27
What nursing interventions would the nurse use to minimize
adverse effects when administering Heparin or a low molecular-weight
heparin (Enoxaparin)? | back 27 - Monitor aPTT every 2-3 days for subcut heparin, every 4-6 hours
for intravenous heparin (control value is 25-35 seconds, therapeutic
is 37.5-87.5 seconds; hold if greater than 87.5 seconds)
- Monitor platelet count every 2-3 days in acute care environments
(Heparin and enoxaparin), Hold dose of heparin or enoxaparin if
platelets drop and notify health care provider
- Monitor for
signs of bleeding- decrease blood pressure, increased heart rate,
easy bruising, excessive bruising, bleeding around IV catheter,
bleeding from nares, blood in stool, blood in urine
|
front 28
What nursing interventions would the nurse use to minimize
adverse effects when administering Heparin or a low molecular-weight
heparin (Enoxaparin)? pt 2 | back 28 - monitor for signs of coagulation- assess the calf area for heat
, redness, pain and swelling (these are the signs of a deep vein
thrombosis)
- avoid invasive procedures if overdose of heparin
or enoxaparin occurs (administer antidote as prescribed (protamine
sulfate)
- administer heparin subcut in abdomen area, avoid
scars, bruises, incisions. Rotate sites. Do not massage injection
site as this can increase bleeding and hematoma formation. Gently
palpate previous injection sites to see if hematomas have
formed
|
front 29
What nursing interventions would the nurse use to minimize
adverse effects when administering Heparin or a low molecular-weight
heparin (Enoxaparin)? pt 3 | back 29 - administer enoxaparin in love handles area (anterolateral
abdomen)
- prefilled syringes come with an air bubble in them
and this should not be dispelled prior to injection.
- This is considered an "air lock" which helps keep
the medication in the subcutaneous tissue.
- Rotate
sites, do not massage injection site as this can increase
bleeding and hematoma formation. Gently palpate previous
injection sites to see if hematomas have formed
|
front 30
What nursing interventions would the nurse use to minimize
adverse effects when administering Heparin or a low molecular-weight
heparin (Enoxaparin)? pt 4 | back 30 - do not administer heparin or enoxaparin IM as this can cause
large hematomas (muscle is more vascular that adipose tissue)
|
front 31 What would the nurse ensure the patient understands when
administering Heparin or a low molecular-weight heparin (Enoxaparin)? | back 31 - use soft bristle toothbrush to help prevent bleeding gums. Use
electric razor when shaving
- do not massage injection sites
because this chance of bleeding and hematoma formation
- teach patient how to self inject enoxaparin if being discharged
home on therapy
- teach patient to report unusual bleeding
and bruising
|
front 32 Before deciding whether the patient receives Warfarin, what are you
looking for in your assessment of the patient? | back 32 - assess past medical history for contraindications: (chronic
bleeding disorders such as hemophilia, renal disease (enoxaparin)
peptic ulcers (can increase chance of GI bleeding)
- assess
current medical issues (acute bleeding processes, hemorrhagic
stroke, pregnancy)
- assess current medications (look for
drug interactions, aspirin, NSAIDS, garlic, other anticoagulants,
antiplatelets, thrombolytics)
- assess dietary intake of food
high in vitamin K
- assess baseline labs (PT, INR)
|
front 33
What nursing interventions would the nurse use to minimize
adverse effects when administering Warfarin? | back 33 - Monitor PT/INR every 2-3 days during initial therapy, once
patient reaches therapeutic level, monitor PT every 2-4 weeks
- (PT range should be 1.25-2.5 the control value = 13.5-37.5
therapeutic PT. INR should be between 2-3 for VTE prophylaxis
and could be up to 3.5 for mechanical heart valve
patients.)
- Monitor for signs of bleeding-
decrease blood pressure, increased heart rate, easy bruising,
excessive bruising, bleeding around IV catheter, bleeding from
nares, blood in stool, blood in urine)
|
front 34
What nursing interventions would the nurse use to minimize
adverse effects when administering Warfarin? pt 2 | back 34 - monitor for signs of coagulation- assess the calf area for
heat, redness, pain and swelling (these are signs of a deep vein
thrombosis)
- If INR will result in maybe a held dose and dose
readjustment by healthcare provider
- protect the patient
from harm if INR elevated above therapeutic levels, fall
precautions, avoid invasive procedures
|
front 35 What would the nurse ensure the patient understands when
administering Warfarin? | back 35 - use soft bristle tooth brush to help prevent bleeding gums. Use
electric razor when shaving
- teach patient to be consistent
in intake of foods high in vitamin K (for example, if you want to
eat salad 3 times a week, then eat salad 3 times a week every week;
if you decide to stop eating salad, make sure your healthcare
provider knows
- Take medication as prescribed
|
front 36 What would the nurse ensure the patient understands when
administering Warfarin? pt 2 | back 36 - follow up lab work every 2-4 weeks' try not to skip these
appointments
|
front 37 What are examples of antiplatelet drugs? | |
front 38 Before deciding whether the patient receives antiplatelet drugs, what
are you looking for in your assessment of the patient? | back 38 - past medical history (look for chronic bleeding disorders,
gastric disorders, gastric ulcers, recent GI bleeding, recent
hemorrhagic stroke)
- drug history, both looking at
prescription and non-prescription (NSAIDS increase chance of
bleeding, anticoagulants increase chance of bleeding)
- assess labs-platelet count, hemoglobin, hematocrit
|
front 39
What would the nurse's plan include when using antiplatelet drugs? | back 39 - the patient will be free from s/s of CVA or MI
|
front 40
What nursing interventions would the nurse use to minimize
adverse effects when administering antiplatelet drugs? | back 40 - monitor for signs of bleeding throughout therapy
- administer with food to help prevent GI ulceration and
bleeding
|
front 41 What would the nurse ensure the patient understands when
administering antiplatelet drugs? | back 41 - teach patient to notify healthcare providers of antiplatelet
therapy. Notify surgeons and dentists, should be held 3-7 days
before surgery (however, that is up to the healthcare provider
)
- teach to take with food to prevent GI ulceration and
bleeding
- Teach to look for signs of GI ulcer (epigastric
pain) and GI bleeding (dark tarry stools, coffee ground emesis);
report these symptoms to healthcare provider if they should
occur
- Teach s&s of stroke and MI and to seek emergency
help
|